(Q33762632)

29 July 2017

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis (English)

1 reference

29 July 2017

0 references

Salomé González-Reyes

1

1 reference

29 July 2017

Laura Marín

2

1 reference

29 July 2017

Lucía González

3

1 reference

29 July 2017

Luis O González

4

1 reference

29 July 2017

José M del Casar

5

1 reference

29 July 2017

Maria L Lamelas

6

1 reference

29 July 2017

José M González-Quintana

7

1 reference

29 July 2017

Francisco J Vizoso

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

3 December 2010

1 reference

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

665

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-665

29 July 2017

0 references

cites work

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Stroma-mediated expression of estrogen and its role in cancer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptor signaling pathway variants and prostate cancer mortality

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Significance of toll-like receptors expression in tumor growth and spreading: a short review

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptors and cancer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Molecular characterisation of the tumour microenvironment in breast cancer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

TLR3 and TLR4 expression in healthy and diseased human endometrium

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Role of toll-like receptors in tissue repair and tumorigenesis

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

TLR signaling by tumor and immune cells: a double-edged sword

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Dendritic cells and cytokines in immune rejection of cancer.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

HPV: from infection to cancer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

NF-kappaB activation in development and progression of cancer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Cancer surveillance in inflammatory bowel disease: new molecular approaches.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

TLR3 can directly trigger apoptosis in human cancer cells.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Role of infiltrated leucocytes in tumour growth and spread

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Toll-like receptors and acquired immunity

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Cancer; a biological approach. I. The processes of control

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

An innate sense of danger

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

A fresh look at tumor immunosurveillance and immunotherapy.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Developmental phases of inflammation-induced massive lymphoid hyperplasia and extensive changes in epithelium in an experimental model of allergy: implications for a direct link between inflammation and carcinogenesis

22 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-665

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-665

Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-665

The effect of the microenvironment of head and neck cancers on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-665

Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-665

[Proteases in cancer progression].

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3009680

'Yin and Yang' in inflammation: duality in innate immune cell function and tumorigenesis

30 October 2018

1 reference

12 December 2020

[Stromal proteases in the progression of breast cancer]

1 reference

12 December 2020

Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors

1 reference

12 December 2020

[Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)]

1 reference

12 December 2020

Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy

1 reference

12 December 2020

An approach for understanding the inflammation and cancer relationship

1 reference

12 December 2020

Stroma -- regulator of cancer cell progression

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-10-665

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference